Summary. Acute hyperinsulinaemias induced by insulin and stimulants of insulin secretion have been shown to cause a translocation of liver insulin receptors from the cell surface to the intracellular compartment, with little or no change in total receptor number. To determine whether a similar phenomenon occurs in chronic hyperinsulinaemic states, we have carried out a longitudinal study of total, cell surface and intracellular liver insulin receptors in genetically obese Zucker rats, with spontaneously develop hyperinsulinaemia. Liver plasma membranes, Golgi-endosomal fractions, a microsomal fraction and a total particulate fraction were isolated in 2-14-week old obese (fa/fa) rats and examined for specific insulin binding relative to lean (Fa/?) age-matched animals. In 16-day old rats, which were still normoinsulinaemic, insulin binding was unchanged. Later on, as hyperinsulinaemia developed, three sequential changes in insulin binding activity were observed: first, a 25-30% increase in Golgiendosomal fractions (20 days); then, a 50-60% decrease in Golgi-endosomal fractions (4-5 weeks); and finally, a 50% decrease in plasma membranes (11 weeks), microsoreal fraction and total particulate fraction (14 weeks), accompanied by restoration in Golgi-endosomal fractions (8-11 weeks). Unlike insulin receptors, insulin extractable from Golgiendosomal fractions at 4-5 weeks was unchanged or increased. We conclude that, although an early increase in the endocytosis of liver insulin receptors may occur in hyperinsulinaemic Zucker rats, this mechanism does not account for the later decrease in cell surface receptors observed in these animals.
A decrease in the concentration of insulin receptors in cells has been observed in a number of rodent models in which plasma insulin concentration is chronically elevated, either spontaneously, such as genetic [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and acquired [15] forms of obesity, or as a result of exogenous insulin administration [16, 17] . This defect has been observed in liver [2-5, 8-13, 15] , fat cells [7] and heart muscle membranes [1] ; in hepatocytes [2, 12] , adipocytes [16] , and thymic lymphocytes [4, 5] ; and in isolated soleus muscle [10] . In most of these animal models, the insulin receptor defect is a function of the degree of the hyperinsulinaemia, suggesting that these two abnormalities are causally related.
The ability of insulin to decrease the concentration of its receptors in isolated cells is also well established [18] . Two basic mechanisms are known to be involved in this process: on the one hand, an increase in the rate of degradation of the receptors, and on the other hand, an increase in their rate of internalisation. Depending on the cell type, either enhanced receptor degradation [19, 20] , or enhanced receptor internalisation [21] , or both [22] , have been reported. Much less is known, however, on the mechanism(s) underlying the insulin receptor defect found in chronic hyperinsutinaemic states.
Previous studies in this laboratory have shown that acute hyperinsulinaemias induced by insulin [23] and stimulants of insulin secretion [24] result in changes in the subcelluIar distribution of liver insulin receptors that suggest enhanced receptor internalisation. To determine whether similar changes occur in chronic hyperinsulinaemic states, we have carried out a longitudinal analysis of the subcellular distribution and the total number of hepatic insulin receptors in genetically obese Zucker rats.
Materials and methods

Animals
Sixteen to 30-day old obese Zucker rats (fa/fa) and their lean littermates (Fa/?) were bred in the laboratory of Inserm U 177, Paris, France, from breeding pairs originally provided by the Harriet G. 
Subcellular fractionation
Subcellular fractions were isolated from pools of 2-3 livers in 16-30-day old rats and from separate livers in older animals. Routinely, 3-6 separate sets of subcellular fractions from both obese rats and their lean age-matched animals were prepared on the same day. A total particulate fraction, a plasma membrane fraction [26] , a microsomal fraction and light, intermediate and heavy Golgi-endosomal fractions [27] were prepared as described previously. Originally isolated on the basis of a high content in the enzyme galactosyltransferase and on the presence of intraluminal lipoprotein particules, Golgi-endosomal fractions are now known to consist of two separate entities: true Golgi elements, which possess galactosyltransferase, and endosomes, which concentrate internalized ligands and presumably also their receptors. Subcellular fractions were stored in liquid nitrogen until used for biochemical determinations.
Biochemical assays
Insulin binding to liver subcellular fractions was measured ind the presence of Triton X-100 (0.05%, wt/vol) using 125I-insulin as a ligand and polyethyleneglycol precipitation as a method to separate free and receptor-bound insulin, as described previously [241. Complete sets of subcellular fractions from livers of lean and obese rats of a given age were always assayed for insulin binding on the same day, and with the same batch of t25I-insulin. For each individual fraction, results (expressed in cpm/mg protein) were the mean of triplicate determinations. Endogenous insulin associated with Golgiendosomal fractions was extracted by 0.1 N HC1 containing 1% (w/v) bovine serum albumin and 0.1% (w/v) bacitracin [24] ; recovery of insulin in the extract, as estimated from parallel experiments with Golgi-endosomal fractions loaded by t25I-insulin in vivo, was at least 90% [23] . Insulin concentration in Golgi-endosoreal extracts and blood plasma was measured by radioimmunoassay, using rat insulin as a standard [24] . Control experiments showed that the amount of endogenous insulin present in Golgi-endosomal fractions did not interfere with the insulin binding assay and, therefore, results did not require ,correction.
Statistical analysis
All statistical comparisons between obese (fa/fa) and lean (Fa/?) rats of the same age were performed using the Student's t-test. For comparisons of insulin binding activities, values obtained in lean and obese rats were converted to percentages of the mean value observed in the lean animals of the same series. Because of the use of different batches of 125I-insulin to assay insulin binding in subcellular fractions from rat of different ages, no longitudinal comparisons were made within the lean or obese groups. Table 1 shows the developmental changes in body weight, liver weight and plasma insulin concentration in obese (fa/fa) and lean (Fa/?) Zucker rats. The body weight and liver weight in obese rats did not differ from those in lean animals until 23 days, but became significantly greate, r (p< 0.01) after 4 weeks. Plasma insulin concentration in obese animals did not significantly differ from that in lean controls at 16 days, but progressively increased after 20 days (about 2, 5 and 10-fold at 23 days, 5 weeks and 11 weeks respectively). Plasma insulin concentration in lean rats did not vary with age.
Results
Body weight, liver weight and plasma insulin concentration
Biochemical characterisation of liver subcellular fractions
Average protein yields Qxg per g liver; mean_+ SEM of 3-7 determinations) in light, intermediate and heavy Golgi-endosomal fractions of 16-day old rats were, respectively, 99+4, 147_+8 and 636+107 in lean rats, and 87+6, 138+8 and 630+154 in obese rats, with no [23] , with no difference between lean and obese rats of the same age.
Specific activities of galactosyltransferase (a Golgi marker) in Golgi-endosomal fractions and 5'nucleotidase (a plasma membrane marker) in plasma membranes of Zucker rats were similar to those previously observed in adult Sprague-Dawley rats [24, 28] and did not differ in lean and obese rats of the same age (data not shown).
Insulin binding to subcellular fractions
In lean Zucker rats, the insulin binding activity of liver subcellular fractions was similar to that previously found in Sprague-Dawley rats [23, 24, 28] , with a marked enrichment of binding activity in plasma membranes and in Golgi-endosomal fractions (about 7 fold and 2-4 fold, respectively; legend to Fig.l) . In general, the subcellular distribution of binding sites was little affected by age, except for a somewhat greater enrichment in the light Golgi-endosomal fraction of 16-23-day old rats.
In 16-day old obese rats, which were still normoinsulinaemic (Table 1) , insulin binding to liver subcel- The techniques used to extract and assay insulin from Golgi-endosomal fractions are described in Materials and methods. The results are the mean _+ SEM of 3 6 determinations on separate fractions, a p< 0.05 vs control lular fractions did not differ significantly from that observed in lean littermates. From 20 days on, however, as the hyperinsulinaemia developed, changes in insulin binding to subcellular fractions progressively occurred. Such changes affected first Golgi-endosomal fractions, then plasma membranes and finally the total particulate and microsomal fractions (Fig. 1) . Insulin binding to Golgi-endosomal fractions of obese rats showed somewhat complex changes, first increasing by 20-30% at 20 days, then decreasing by 40-60% at 4-5 weeks, and finally increasing again towards control values after 8 weeks. The initial increase in insulin binding observed in 20-day old rats affected identically the three Golgi-endosomal fractions (Fig. 1,  panels A, B, C) , but the subsequent decrease in binding was somewhat greater in the light fraction, and so was the late increase in binding. Scatchard plots constructed from competitive inhibition curves by unlabelled insulin showed that the decreased ability of Golgi-endosomal fractions to bind insulin observed in 30-day old obese rats resulted from a decrease in binding capacity, with little or no change in affinity (Fig. 2) .
Insulin binding to other subcellular fractions was virtually unaffected until the age of 4 weeks (Fig. 1, panels D, E) . Insulin binding to plasma membranes progressively decreased after 5 weeks, reaching about 80% of control values at 8 weeks and 50% at 11 weeks. Insulin binding to the total particulate and microsomal fractions decreased more slowly and to a lesser extent, reaching about 80% and 60% of control values at 11 and 14 weeks respectively.
In the experiments described above, insulin binding activities in liver subcellular fractions were related to protein. Although protein yields of Golgi-endosomal fractions after 20 days somewhat differed in lean and obese rats, relative changes in insulin binding in obese rats were comparable when results were related to liver weight. However, due to an increase in liver weight in obese rats after 5 weeks, total receptor number was unchanged when related to the whole organ.
Insulin content of Golgi-endosomal fractions
When related to protein, the insulin content of the heavy Gotgi-endosomal fraction was increased by 3-fold in 30-day old rats relatively to lean animals, but not such a change was observed in the intermediate Golgi-endosomal fraction of 30-day old rats, and in Golgi-endosomal fractions of 8 and 1a-week old rats (Table 2) . When related to liver weight, insulin content in the intermediate Golgi-endosomal fraction of 8 and tl week-old obese animals was also increased. Thus, the decrease in insulin receptor number occurring in the intermediate and heavy Golgi-endosomal fractions of 30-day old rats was not accompanied by a parallel decrease in extractable insulin content, as would be expected if receptor endocytosis were diminished [281.
Discussion
A number of studies, utilising isolated liver subcellular fractions [9, 11, 13, 14, 29] , isolated hepatocytes [12, 30] and whole liver [12, 311 have examined the ability of insulin to bind to its receptors in genetically obese Zucker rats. Although a reduced number of hepatic receptors, when related to membrane protein, cell number or tissue weight, has been consistently observed in animals aged more than 4 months [9, 11, 14] , results obtained in 9-12-week old animals have been contradictory [10, 13, 14, 29, 30] . In addition, no studies have been performed in younger animals, in spite of the fact that hyperinsulinaemia already occurs at 3 weeks of age [32, 33] , nor have the insulin receptors in the Golgiendosomal compai~ment been examined.
The present studies confirm that the decrease in the number of insulin receptors in liver plasma membranes of genetically obese Zucker rats is age-related, although occurring earlier (8 weeks) than found by other authors [9] . Furthermore, they show that the changes in insulin binding affect not only plasma membranes but also the Golgi-endosomal fractions, each fraction being affected in a specific manner and with a specific temporal sequence. In 16-day old rats, no changes in insulin binding were detectable. At 20 days, as plasma insulin concentration began to rise, the only change detectable was a 25-30% increase in insulin binding activity in Golgi-endosomal fractions. From 3 to 5 weeks, binding activity decreased by 50-60% in Golgi-endosomal fractions; concomittantly, insulin extractable from the latter increased by 3-fold.
After 5 weeks, binding activity decreased by 50% in plasma membranes and in the total particulate fraction, while being partially restored in Golgi-endosomal fractions.
After 3 weeks of age, the changes affecting insulin binding activity in obese Zucker rats clearly differed from those observed in rats rendered acutely hyperinsulinaemic by insulin [23] and stimulants of insulin secretion [24] . Indeed, in these acute hyperinsulinaemic states, the decrease in the number of cell-surface insulin receptors was associated with an increase in the number of intracellular receptors, and total receptor number was unaffected [23, 24] . In addition, although both 8-11-week old Zucker rats (present study) and glucose injected rats [24] displayed the same degree of hyperinsulinaemia, only in the latter was the insulin content of Golgi-endosomal fractions increased. On the other hand, the changes observed in Zucker rats more closely resemble those described in genetically obese ob/ob [2, 3] and db/db [3] mice. In these models, receptor number was decreased in plasma membranes, in the intermediate Golgi-endosomal fraction and in whole homogenates [2] , especially the former. However, unlike in Zucker rats, insulin binding activity in the heavy Golgi-endosomal fraction of obese mice was either unaffected (ob/ob model) or slightly increased (db/db model) [3] . Differences in the stage of the hyperinsulinaemia at which these models were studied might explain these discrepancies.
Based on the changes in the subcellular distribution of the receptors, we have earlier suggested that, in acute hyperinsulinaemic states, increased receptor internalisation is the major mechanism by which insulin regulates the concentration of its receptors at the surface of liver cells [23, 24] . That an increase in receptor internalisation also occurs in genetically obese hyperinsulinaemic Zucker rats, at least at an early stage, is suggested by the increase in insulin binding activity and insulin content in Golgi-endosomal fractions which occurs at 20 and 30 days respectively. A similar mechanism may also explain the increased number of insulin receptors in the heavy Golgi-endosomal fraction of db/db mice reported previously [3] . However, the decrease in total cellular receptor number which occurs in both hyperinsulinaemic rodent models suggests that, at least at a late stage, an enhanced receptor degradation and/or a reduced receptor synthesis is/are the major mechanism(s) involved.
Recent studies using the diaminobenzidine density shift technique [34] have shown that liver Golgi-endosomal fractions as prepared in this work can be resolved in Golgi and endosomal components. Although insulin internalised into crude Golgi-endosomal fractions has been shown to associate exclusively with endosomes [35] , it is unknown whether the internalised receptors also associates with this structure. Quantification of the receptors in physically resolved Golgi and endosomal components should help to elucidate the mechanisms by which acute [23, 24] and chronic hyperinsulinaemias regulate receptor number and distribution in liver cells.
